|
If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.
It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.
Wiley InterScience | ||||||||||
  Headache: The Journal of Head and Face PainVolume 39 Issue 9, Pages 650 - 653 Published Online: 17 Jun 2002 © 2010 American Headache Society Published on behalf of the American Headache Society
Abstract | Full Text: PDF (Size: 485K) | Related Articles | Citation Tracking  Management of Chronic Daily Headache Utilizing a Uniform Treatment Pathway Copyright © 1999 American Headache Society (formerly the American Association for the Study of Headache) KEYWORDS primary chronic daily headache • uniform treatment pathway ABSTRACTObjective.—To determine if the use of a uniform treatment pathway might be effective in treating patients with primary chronic daily headache. Methods.—Thirty-three consecutive patients with primary chronic daily headache were managed according to a treatment pathway which involved sequential administration of divalproex sodium, amitriptyline, amitriptyline plus phenelzine, or methadone. Results.—Twenty-two patients (67%) reported a 50% or greater reduction in headache days per month following initiation of treatment. Most positive treatment responses (17 [77%] of 22) were attributed to divalproex sodium. Conclusion.—Implementation of a uniform treatment pathway may result in significant clinical improvement in a sizable proportion of patients with chronic daily headache. Accepted for publication February 7, 1999. | 
|
